Showing 41,461 - 41,480 results of 49,013 for search '(( 50 ((a decrease) OR (nn decrease)) ) OR ( a ((fold decrease) OR (point decrease)) ))', query time: 1.05s Refine Results
  1. 41461

    Data_Sheet_5_Cell Line-, Protein-, and Sialoglycosite-Specific Control of Flux-Based Sialylation in Human Breast Cells: Implications for Cancer Progression.pdf by Christopher T. Saeui (4246210)

    Published 2020
    “…A third category—protein folding chaperones—was unexpected because little precedent exists for the role of glycosylation in the activity of these proteins. …”
  2. 41462
  3. 41463
  4. 41464
  5. 41465

    Data_Sheet_1_Sleep duration and depression among adolescents: Mediation effect of collective integration.docx by Min Gao (87060)

    Published 2022
    “…The analytic sample in the present study included 8,829 seventh-grade students aged about 14 years (51.50% boys and 48.50% girls). A structural equation modeling (SEM) was used to investigate parent–child/teacher factors affecting adolescent sleep duration and depression, and Monte Carlo resampling with R was employed to confirm the significance of the mediation effects of collective integration. …”
  6. 41466
  7. 41467

    Table3_Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS).DOCX by Ming-Tao Wen (16530297)

    Published 2024
    “…</p>Results<p>Out of 107,123 reports with teriparatide as the primary suspect, key AEs identified included pain in extremity (PRR: 4.54), muscle spasms (PRR: 5.11), fractures (PRR range: 17.67–552.95), and increased calcium levels (PRR: 50.73). Teriparatide exhibited a stronger association with increased calcium levels (PRR: 50.73) compared to fractures (PRR range: 17.67–552.95). …”
  8. 41468

    Table 1_Concomitant autoimmunity and late cancers in adult-onset immunodeficiency due to neutralizing anti-IFN-γ autoantibodies.docx by Wan-Ting Tsai (492227)

    Published 2025
    “…</p>Methods<p>This study included 50 patients diagnosed with adult-onset immunodeficiency due to nAIGA between 2014-2024. …”
  9. 41469
  10. 41470
  11. 41471
  12. 41472
  13. 41473
  14. 41474

    Table4_Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS).DOCX by Ming-Tao Wen (16530297)

    Published 2024
    “…</p>Results<p>Out of 107,123 reports with teriparatide as the primary suspect, key AEs identified included pain in extremity (PRR: 4.54), muscle spasms (PRR: 5.11), fractures (PRR range: 17.67–552.95), and increased calcium levels (PRR: 50.73). Teriparatide exhibited a stronger association with increased calcium levels (PRR: 50.73) compared to fractures (PRR range: 17.67–552.95). …”
  15. 41475
  16. 41476
  17. 41477
  18. 41478
  19. 41479
  20. 41480